Clustering data with hclust algorithm for Changes in the Canine Plasma Lipidome after Short- and Long-Term Excess Glucocorticoid Exposure (Study ST001140)
Triacylglycerols (Analysis AN001873)Metabolite | Structure | F1 | F2 | F3 | F4 |
---|---|---|---|---|---|
TG(57:3) | ME272227 | NA | NA | 1.24 | 0.76 |
TG(54:1) | ME272216 | NA | NA | 0.09 | 1.91 |
TG(52:5) | ME272214 | NA | NA | 0.70 | 1.30 |
TG(54:6) | ME272221 | NA | NA | 0.70 | 1.30 |
TG(57:1) | ME272226 | NA | NA | 0.38 | 1.74 |
TG(56:5) | ME272224 | NA | NA | 0.57 | 1.43 |
TG(50:2) | ME272203 | NA | NA | 0.46 | 1.54 |
TG(50:3) | ME272204 | NA | NA | 0.48 | 1.52 |
TG(46:1) | ME272195 | 1.27 | 0.73 | NA | NA |
TG(48:0) | ME272197 | 0.95 | 1.05 | NA | NA |
TG(53:2) | ME272215 | 1.01 | 0.60 | 0.25 | 2.27 |
TG(50:0) | ME272201 | 0.98 | 1.38 | 0.14 | 1.37 |
TG(51:0) | ME272206 | 0.86 | 1.25 | 0.25 | 1.48 |
TG(54:2) | ME272217 | 1.16 | 0.79 | 0.14 | 1.91 |
TG(55:0) | ME272222 | 1.05 | 0.78 | 0.56 | 1.66 |
TG(50:1) | ME272202 | 1.22 | 1.08 | 0.18 | 1.42 |
TG(54:5) | ME272220 | 1.03 | 1.10 | 0.34 | 1.49 |
TG(51:1) | ME272207 | 1.07 | 1.03 | 0.15 | 1.73 |
TG(52:1) | ME272210 | 1.13 | 0.99 | 0.14 | 1.69 |
TG(52:2) | ME272211 | 1.08 | 0.96 | 0.37 | 1.57 |
TG(54:4) | ME272219 | 1.19 | 0.90 | 0.35 | 1.54 |
TG(54:3) | ME272218 | 1.17 | 0.81 | 0.29 | 1.75 |
TG(51:2) | ME272208 | 1.06 | 0.92 | 0.33 | 1.69 |
TG(51:3) | ME272209 | 1.08 | 0.86 | 0.39 | 1.69 |
TG(50:4) | ME272205 | 1.42 | 0.60 | 0.55 | 1.42 |
TG(55:1) | ME272223 | 1.09 | 0.68 | 0.86 | 1.45 |
TG(48:2) | ME272199 | 1.47 | 1.05 | 0.34 | 0.97 |
TG(46:2) | ME272196 | 1.62 | 0.89 | 0.42 | 0.90 |
TG(48:3) | ME272200 | 1.58 | 0.78 | 0.58 | 0.95 |
TG(48:1) | ME272198 | 1.12 | 1.19 | 0.40 | 1.19 |
TG(52:3) | ME272212 | 1.21 | 1.01 | 0.62 | 1.08 |
TG(52:4) | ME272213 | 1.29 | 0.88 | 0.55 | 1.23 |
TG(56:6) | ME272225 | 1.25 | 0.83 | 0.56 | 1.32 |
Factors:
F1 | TreatmentGroup:Prednisolone | TreatmentDuration:0d | SamplingTimePoint:before |
F2 | TreatmentGroup:Prednisolone | TreatmentDuration:4d | SamplingTimePoint:after |
F3 | TreatmentGroup:Tetracosactide | TreatmentDuration:00w | SamplingTimePoint:before |
F4 | TreatmentGroup:Tetracosactide | TreatmentDuration:25w | SamplingTimePoint:after |